KLOR-CON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Klor-con, and what generic alternatives are available?
Klor-con is a drug marketed by Upsher Smith Labs and is included in four NDAs.
The generic ingredient in KLOR-CON is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-eight suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Klor-con
A generic version of KLOR-CON was approved as potassium chloride by ACTAVIS LABS FL INC on April 10th, 2002.
Summary for KLOR-CON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 314 |
Patent Applications: | 300 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for KLOR-CON |
Drug Sales Revenues: | Drug sales revenues for KLOR-CON |
What excipients (inactive ingredients) are in KLOR-CON? | KLOR-CON excipients list |
DailyMed Link: | KLOR-CON at DailyMed |
Pharmacology for KLOR-CON
Drug Class | Osmotic Laxative Potassium Salt |
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |